Ganchimeg Bayarsaikhan, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria | 9 | 2023 | 1239 | 1.380 |
Why?
|
| Plasmodium berghei | 4 | 2022 | 168 | 0.810 |
Why?
|
| Plasmodium chabaudi | 3 | 2023 | 22 | 0.650 |
Why?
|
| Antigens, Protozoan | 2 | 2017 | 322 | 0.520 |
Why?
|
| Spleen | 2 | 2021 | 2359 | 0.400 |
Why?
|
| Parasitemia | 2 | 2018 | 173 | 0.300 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10179 | 0.290 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 4477 | 0.280 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2023 | 4386 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2023 | 343 | 0.230 |
Why?
|
| Integrin alpha4 | 1 | 2021 | 92 | 0.200 |
Why?
|
| Malaria Vaccines | 1 | 2022 | 158 | 0.190 |
Why?
|
| Plasmodium yoelii | 1 | 2018 | 39 | 0.170 |
Why?
|
| Dendritic Cells | 3 | 2021 | 2720 | 0.160 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2018 | 10 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2022 | 541 | 0.160 |
Why?
|
| Lymphocyte Activation | 5 | 2021 | 5524 | 0.140 |
Why?
|
| Immunity | 1 | 2023 | 1013 | 0.140 |
Why?
|
| Th1 Cells | 1 | 2021 | 1057 | 0.140 |
Why?
|
| Ovalbumin | 1 | 2017 | 719 | 0.130 |
Why?
|
| Listeria monocytogenes | 1 | 2017 | 250 | 0.130 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 9731 | 0.120 |
Why?
|
| Antigen Presentation | 1 | 2017 | 1283 | 0.100 |
Why?
|
| Metformin | 1 | 2018 | 837 | 0.100 |
Why?
|
| Mice | 8 | 2023 | 81154 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2023 | 21824 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 1837 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 1821 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2017 | 1347 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2017 | 3205 | 0.080 |
Why?
|
| Animals | 9 | 2023 | 168660 | 0.070 |
Why?
|
| Macrophages | 1 | 2018 | 5651 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2021 | 193 | 0.050 |
Why?
|
| Apoptosis | 1 | 2017 | 9718 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2022 | 19232 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 844 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 2017 | 223 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18027 | 0.040 |
Why?
|
| Hybridomas | 1 | 2017 | 452 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 791 | 0.030 |
Why?
|
| Malaria, Cerebral | 1 | 2017 | 135 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2022 | 1608 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2017 | 526 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2021 | 985 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 880 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2018 | 1211 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6380 | 0.020 |
Why?
|
| Humans | 3 | 2023 | 743811 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 63042 | 0.010 |
Why?
|
| Female | 1 | 2018 | 380020 | 0.000 |
Why?
|